Advanced breast cancer represents a challenge for patients and for physicians due its dynamic genomic changes yielding to a resistance to treatments. The main goal is to improve quality of live and survival of the patients through the most appropriate subsequent therapies based on the knowledge of the natural history of the disease. In these guidelines, we summarize current evidence and available therapies for the medical management of advanced breast cancer.
Advanced breast cancer; Anti-HER2 therapy; Endocrine therapy
Garcia-Saenz JA, Blancas I, Echavarria I, Hinojo C, Margeli M, Moreno F, et al. SEOM–GEICAM–SOLTI clinical guidelines in advanced breast cancer (2022). Clin Transl Oncol. 2023 Sep;25:2665–78.
Use this identifier for quote and/or link this documenthttps://hdl.handle.net/11351/10245
The following license files are associated with this item: